Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER × tinostamustine × Clear all

Phase

Phase 1 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Cisplatin 53 Cyclophosphamide 42 Fluorouracil 41 Oxaliplatin 36 Capecitabine 35 Docetaxel 34 Drug Therapy 32 Radiotherapy 31 Gemcitabine 30 Paclitaxel 25 Carboplatin 23 Dexamethasone 22 Leucovorin 21 Etoposide 17 Doxorubicin 17 apatinib 16 Methotrexate 16 Cytarabine 16 Radiation 13 Magnetic Resonance Spectroscopy 13 Epirubicin 13 Busulfan 13 Surgical Procedures, Operative 12 Neoadjuvant Therapy 12 Letrozole 12 Decitabine 12 Bevacizumab 12 Saline Solution 11 venetoclax 10 fludarabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03970447 2026-04-08

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡